Radix clematidis extract protects against cytokine-and streptozotocin-induced β-cell damage by suppressing the NF-κB pathway

International Journal of Molecular Medicine

Volumn 22, Issue 3, 2008, Pages 349-356

  Kim, Eun Kyung ^a   Song, Mi Young ^a   Hwang, Tae Ok ^b   Kim, Hee Jin ^a   Moon, Woo Sung ^a   Ryu, Do Gon ^b   So, Hong Seob ^c   Park, Raekil ^c   Park, Jin Woo ^a   Kwon, Kang Beom ^b   Park, Byung Hyun ^a  

^a Chonbuk National University   (South Korea)

^b Wonkwang University   (South Korea)

^c Wonkwang University   (South Korea)

Author keywords

cells; Cytokine; NF B; Nitric oxide; Radix clematidis; Streptozotocin

Indexed keywords

ANTIDIABETIC AGENT; CLEMATIDIS EXTRACT; GAMMA INTERFERON; GLUCOSE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE; STREPTOZOCIN; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG; CYTOKINE; INSULIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL DAMAGE; CELL NUCLEUS; CELL VIABILITY; CLEMATIDIS; CLEMATIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSOL; DRUG MECHANISM; DRUG PROTEIN BINDING; GENE EXPRESSION; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULINOMA; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PLANT ROOT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; STREPTOZOCIN DIABETES; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL PROTECTION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GASTROPOD; MALE; METABOLISM; RAT; SECRETION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; CYTOPROTECTION; GASTROPODA; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; MALE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STREPTOZOCIN;

EID: 53049098766     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm_00000029     Document Type: Article

References (31)

1. Nossal GJ, Herold KC and Goodnow CC: Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35 (Suppl 2): S49-S59, 1992.
2. Papaccio G: Insulitis and islet microvasculature in type 1 diabetes. Histol Histopathol 8: 751-759, 1993.
3. Scherbaum WA: Etiology and pathogenesis of type 1 diabetes. Horm Metab Res (Suppl) 26: 111-116, 1992.
4. Hohmeier HE, Tran VV, Chen G, Gasa R and Newgard CB: Inflammatory mechanisms in diabetes: lessons from the β cell. Int J Obes Relat Metab Disord 27 (Suppl 3): S12-S16, 2003.
5. Arnush M, Heitmeier MR, Scarim AL, Marino MH, Manning PT and Corbett JA: IL-1 produced and released endogenously within human islets inhibits β cell function. J Clin Invest 102: 516-526, 1998.
6. Cetkovic-Cvrlje M and Eizirik DL: TNF-α and IFN-γ potentiate the deleterious effects of IL-1β on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine 6: 399-406, 1994.
7. Kaneto H, Fujii J, Seo HG, Suzuki K, Matsuoka T, Nakamura M, Tatsumi H, Yamasaki Y, Kamada T and Taniguchi N: Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 44: 733-738, 1995.
8. Stadler J, Billiar TR, Curran RD, Stuehr DJ, Ochoa JB and Simmons RL: Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol 260: C910-C916, 1991.
9. Carlsson PO, Flodstrom M and Sandler S: Islet blood flow in multiple low dose streptozotocin-treated wild-type and inducible nitric oxide synthase-deficient mice. Endocrinology 141: 2752-2757, 2000.
10. Tsuji A and Sakurai H: Generation of nitric oxide from streptozotocin (STZ) in the presence of copper(II) plus ascorbate: implication for the development of STZ-induced diabetes. Biochem Biophys Res Commun 245: 11-16, 1998.
11. Giannoukakis N, Rudert WA, Trucco M and Robbins PD: Protection of human islets from the effects of interleukin-1β by adenoviral gene transfer of an IκB repressor. J Biol Chem 275: 36509-36513, 2000.
12. Heimberg H, Heremans Y, Jobin C, Leemans R, Cardozo AK, Darville M and Eizirik DL: Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents β-cell apoptosis. Diabetes 50: 2219-2224, 2001.
13. Kim EK, Kwon KB, Koo BS, Han MJ, Song MY, Song EK, Han MK, Park JW, Ryu DG and Park BH: Activation of peroxisome proliferator-activated receptor-γ protects pancreatic β-cells from cytokine-induced cytotoxicity via NF-κB pathway. Int J Biochem Cell Biol 39: 1260-1275, 2007.
14. Baeuerle PA and Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12: 141-179, 1994.
15. Baldwin AS Jr: The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683, 1996.
16. Moncada S, Palmer RM and Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
17. Park BH, Rho HW, Park JW, Cho CG, Kim JS, Chung HT and Kim HR: Protective mechanism of glucose against alloxan-induced pancreatic β-cell damage. Biochem Biophys Res Commun 210: 1-6, 1995.
18. Kim EK, Kwon KB, Han MJ, Song MY, Lee JH, Lv N, Ka SO, Yeom SR, Kwon YD, Ryu DG, Kim KS, Park JW, Park R and Park BH: Coptidis rhizoma extract protects against cytokine-induced death of pancreatic β-cells through suppression of NF-κB activation. Exp Mol Med 39: 149-159, 2007.
19. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S and Eizirik DL: Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54 (Suppl 2): S97-S107, 2005.
20. Mandrup-Poulsen T: β cell death and protection. Ann NY Acad Sci 1005: 32-42, 2003.
21. McDaniel ML, Kwon G, Hill JR, Marshall CA and Corbett JA: Cytokines and nitric oxide in islet inflammation and diabetes. Proc Soc Exp Biol Med 211: 24-32, 1996.
22. Darville MI and Eizirik DL: Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NF-κB and C/EBP. Diabetes 50: 1741-1748, 2001.
23. May MJ and Ghosh S: Signal transduction through NF-κB. Immunol Today 19: 80-88, 1998.
24. Steinle AU, Weidenbach H, Wagner M, Adler G and Schmid RM: NF-κB/ Rel activation in cerulein pancreatitis. Gastroenterology 116: 420-430, 1999.
25. Karin M and Lin A: NF-κB at the crossroads of life and death. Nat Immunol 3: 221-227, 2002.
26. Liuwantara D, Elliot M, Smith MW, Yam AO, Walters SN, Marino E, McShea A and Grey ST: Nuclear factor-κB regulates β-cell death: a critical role for A20 in β-cell protection. Diabetes 55: 2491-2501, 2006.
27. Chang I, Kim S, Kim JY, Cho N, Kim YH, Kim HS, Lee MK, Kim KW and Lee MS: Nuclear factor-κB protects pancreatic β-cells from tumor necrosis factor-α-mediated apoptosis. Diabetes 52: 1169-1175, 2003.
28. Elsner M, Guldbakke B, Tiedge M, Munday R and Lenzen S: Relative importance of transport and alkylation for pancreatic β-cell toxicity of streptozotocin. Diabetologia 43: 1528-1533, 2000.
29. Lamhamedi-Cherradi SE, Zheng S, Hilliard BA, Xu L, Sun J, Alsheadat S, Liou HC and Chen YH: Transcriptional regulation of type I diabetes by NF-κB. J Immunol 171: 4886-4892, 2003.
30. Mabley JG, Hasko G, Liaudet L, Soriano F, Southan GJ, Salzman AL and Szabo C: NFκB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes. J Endocrinol 173: 457-464, 2002.
31. Buteau J, El-Assaad W, Rhodes CJ, Rosenberg L, Joly E and Prentki M: Glucagon-like peptide-1 prevents β cell glucolipotoxicity. Diabetologia 47: 806-815, 2004.